Gabay Avraham bought ORMP
December 31, 2025 · Form 4 insider transaction
Gabay Avraham bought 19,000 shares of Oramed Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,000
Price
$0.00
Total value
N/A
InsiderGabay Avraham
Role—
SecurityPerformance Stock Units
Transaction codeA: Grant or award
Transaction dateDecember 31, 2025
Filing dateJanuary 2, 2026
Shares owned after19,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.